World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
10382
World Ranking
4227
National Ranking
1927

Overview

John D. Roback is an academic affiliated with Emory University in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, hematology, physiology, genetics, and molecular biology.

The scientist's work covers several key topics, including:

  • SARS-CoV-2 and COVID-19 research
  • Blood groups and transfusion
  • COVID-19 clinical research studies
  • SARS-CoV-2 detection and testing
  • Erythrocyte function and pathophysiology
  • Blood transfusion and management
  • Hemoglobinopathies and related disorders

Notable recent papers by John D. Roback include:

  • Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients, 2020, Cell Reports Medicine
  • Convalescent Plasma to Treat COVID-19, 2020, JAMA
  • Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • The SARS-CoV-2 Receptor-Binding Domain Preferentially Recognizes Blood Group A, 2021, Blood Advances
  • Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System, 2021, Annals of Internal Medicine

Frequent co-authors collaborating with Roback include:

  • Sean R. Stowell
  • Andrew S. Neish
  • Hans Verkerke
  • Narayanaiah Cheedarla
  • Cassandra D. Josephson

The main publication venues where Roback's work appears are:

  • Transfusion
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Open Forum Infectious Diseases
  • Blood Advances

John D. Roback's research contributions are concentrated largely on infectious diseases and hematology, with a substantial body of work addressing COVID-19 and blood transfusion topics. Their presence in both peer-reviewed journals and preprint repositories illustrates participation in rapid dissemination of findings, particularly in the context of the SARS-CoV-2 pandemic.

Best Publications

  • Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.

    John D. Roback;Jeannette Guarner

  • Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells

    Jeanne E. Hendrickson;Maxime Desmarets;Seema S. Deshpande;Traci E. Chadwick

  • Blood Transfusion and Breast Milk Transmission of Cytomegalovirus in Very Low-Birth-Weight Infants A Prospective Cohort Study

    Cassandra D. Josephson;Angela M. Caliendo;Kirk A. Easley;Andrea Knezevic

  • Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.

    Jeanne E. Hendrickson;Traci E. Chadwick;John D. Roback;Christopher D. Hillyer

  • Platelets confound the measurement of extracellular miRNA in archived plasma.

    Adam J. Mitchell;Warren D. Gray;Salim S. Hayek;Yi-An Ko

  • CMV DNA is rarely detected in healthy blood donors using validated PCR assays.

    John D. Roback;W. Lawrence Drew;Megan E. Laycock;Deborah Todd

  • The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy.

    Ian B. Copland;Marco A. Garcia;Edmund K. Waller;John D. Roback

  • Daratumumab (anti-CD38) induces loss of CD38 on red blood cells

    Harold C. Sullivan;Christian Gerner-Smidt;Ajay K. Nooka;Connie M. Arthur

  • The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A.

    Shang-Chuen Wu;Connie M Arthur;Jianmei Wang;Hans Verkerke

  • Metabolic pathways that correlate with post-transfusion circulation of stored murine red blood cells.

    Karen de Wolski;Xiaoyoun Fu;Larry J. Dumont;John D. Roback

  • IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

    Ying Lu;Cynthia R. Giver;Akshay Sharma;Jian Ming Li

  • BDNF‐activated Sianal Transduction in Rat Cortical Glial Cells

    John D. Roback;H. Nicholas Marsh;Martha Downen;H. Clive Palfrey

  • Latent cytomegalovirus infection exacerbates experimental colitis.

    Chukwuma Onyeagocha;Mohammad S. Hossain;Amrita Kumar;Rheinallt M. Jones

  • Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

    Unknown

  • Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration.

    Jennifer K. Frediani;Joshua M. Levy;Anuradha Rao;Leda Bassit

  • Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells

    Jeanne E. Hendrickson;John D. Roback;Christopher D. Hillyer;Kirk A. Easley

  • Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity

    Mohammad S. Hossain;David L. Jaye;Brian P. Pollack;Brian P. Pollack;Alton B. Farris

  • An automatable format for accurate immunohematology testing by flow cytometry.

    John D. Roback;Sheilagh Barclay;Christopher D. Hillyer

  • Anemia induces gut inflammation and injury in an animal model of preterm infants

    Connie M. Arthur;Demet Nalbant;Henry A. Feldman;Bejan J. Saeedi

  • Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice.

    Patricia E Zerra;Seema R Patel;Ryan Philip Jajosky;Connie M Arthur

  • Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infections.

    J.D. Roback;R.A. Bray;C.D. Hillyer

  • Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow.

    Kristina B. Clark;Sansanee Noisakran;Sansanee Noisakran;Nattawat Onlamoon;Nattawat Onlamoon;Hui-Mien Hsiao

  • AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections

    Nancy M. Heddle;Nancy M. Heddle;Michael Boeckh;Brenda Grossman;Jessica Jacobson

  • The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody–positive or –negative components

    Steven H. Kleinman;Darrell J. Triulzi;Edward L. Murphy;Patricia M. Carey

  • Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020.

    William T. Hu;J. Christina Howell;Tugba Ozturk;Karima Benameur

Frequent Co-Authors

James C. Zimring
James C. Zimring University of Washington
Kirk A. Easley
Kirk A. Easley Emory University
Edmund K. Waller
Edmund K. Waller Emory University
Steven L. Spitalnik
Steven L. Spitalnik Columbia University
Jeanne E. Hendrickson
Jeanne E. Hendrickson Yale University
Andrew T. Gewirtz
Andrew T. Gewirtz Georgia State University
Christopher R. Flowers
Christopher R. Flowers The University of Texas MD Anderson Cancer Center
Sagar Lonial
Sagar Lonial Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology and related healthcare fields, exploring online degree options can be a strategic move. Many professionals pursue specialized programs such as the cheapest psych np programs online to enhance their qualifications without incurring excessive costs.

Understanding potential earnings is crucial when considering further education. For example, individuals earning a Doctor of Nursing Practice (DNP) often evaluate how much does a dnp make varies by state and specialization, offering insight into long-term financial benefits.

Career transitions are also common within healthcare, and those with a Family Nurse Practitioner (FNP) background might seek guidance on fnp to acute care np pathways, allowing them to move into specialized, fast-paced environments.

For accelerated advancement, professionals can consider accelerated np programs that offer a faster track to becoming a nurse practitioner. These programs are ideal for those ready to quickly expand their expertise and leadership roles.

Best Scientists Citing John D. Roback

Trending Scientists